Adcendo
Copenhagen, Denmark · Founded 2017 · $135.0M raised
- Headquarters
- Copenhagen
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- adcendo.com
- Total Funding
- $135.0M
- Last Round
- $135.0M Series BNov 2024
- Rounds
- 1
About
Clinical-stage biotech developing antibody-drug conjugates (ADCs) for targeted cancer treatment, spun out of Rigshospitalet and University of Copenhagen.
Summary
Adcendo is a Biotech company based in Copenhagen, Denmark, founded in 2017. It has raised $135.0M in total across 1 round, most recently a $135.0M Series B round in Nov 2024.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2024
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...